TSHA
#2051
Taysha Gene Therapies, Inc. - Common Stock
5.7 8 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.02%
Monthly Change
+6.84%
6 month change
+29.89%
Year Change
+103.52%
Previous Close
5.9 6
Open
5.7 6
Low
5.7 4
High
5.8 0
Volume
534
Financials
- Market Capitalization 1.88 B
- Employee 99
- Founded 2019
- CEO N/A
- Website www.tayshagtx.com
- Headquarter Delaware, United States
- FIGI BBG00TJXFDP1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-16.18
Price to sales ratio
179.93
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2017 |  NBTX Nanobiotix S.A. - ADSs | 41.08 USD | -9.03% | -5.67% | +9.49% | +341.72% | 1.99 B USD | ||
| 2025 |  XNCR Xencor, Inc. - Common Stock | 26.02 USD | -9.90% | -6.40% | +30.56% | +221.23% | 1.93 B USD | ||
| 2052 |  IMCR Immunocore Holdings plc - American Depositary Shares | 36.38 USD | -1.01% | -1.14% | +8.89% | +8.66% | 1.87 B USD | ||
| 2061 |  VIR Vir Biotechnology, Inc. - Common Stock | 10.92 USD | -3.45% | +12.46% | +23.53% | +82.61% | 1.85 B USD |
Frequently asked questions about Taysha Gene Therapies, Inc. Common Stock
What is the Taysha Gene Therapies, Inc. Common Stock stock price today?
The current price of Taysha Gene Therapies, Inc. Common Stock (TSHA) is 5.78. Over the past 24 hours, the stock has changed by -3.02%. Follow the TSHA chart for real-time price dynamics.
What is the stock ticker of Taysha Gene Therapies, Inc. Common Stock?
Taysha Gene Therapies, Inc. Common Stock trades under the ticker TSHA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Taysha Gene Therapies, Inc. Common Stock stock going up?
TSHA has changed by -5.09% over the last week, +6.84% over the last month, and +103.52% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Taysha Gene Therapies, Inc. Common Stock?
Taysha Gene Therapies, Inc. Common Stock currently has a market capitalization of 1.88 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Taysha Gene Therapies, Inc. Common Stock earnings last quarter?
Last quarter, Taysha Gene Therapies, Inc. Common Stock reported earnings of -0.13 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Taysha Gene Therapies, Inc. Common Stock revenue for the last quarter?
Taysha Gene Therapies, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Taysha Gene Therapies, Inc. Common Stock net income for the last quarter?
Taysha Gene Therapies, Inc. Common Stock reported net income of -46.64 M for the last quarter. The previous quarter showed -42.41 M, which means net income changed by -9.97%.
How many employees does Taysha Gene Therapies, Inc. Common Stock have?
As of the latest available data, Taysha Gene Therapies, Inc. Common Stock has 99 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Taysha Gene Therapies, Inc. Common Stock stock?
You can buy Taysha Gene Therapies, Inc. Common Stock (TSHA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Taysha Gene Therapies, Inc. Common Stock stock?
Investing in Taysha Gene Therapies, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TSHA chart and related analysis on metatrader.com as part of your research.